Anne Wojcicki is committed to resuming the personal genomics company’s test for pharmacogenetics and disease risks.
Anne Wojcicki is the first to admit that she has tunnel vision. The battle-weary CEO of 23andMe knows exactly where her company needs to be in the next five years.
